The hyperglycemia: intensive insulin infusion in infarction (HI-5) study was a prospective randomized-controlled trial investigating the effect of intensive insulin therapy on mortality in patients with an acute myocardial infarction [13]. The gene discussed is INS; the disease is acute myocardial infarction.